MIOX and liver dysplastic nodule: In diabetic nephropathy (DN) models, hyperglycemic conditions are reported to promote hypomethylation-dependent binding of the transcription factor Sp-1 to the MIOX promoter, resulting in upregulation of MIOX expression.